Campath - 1H Emerging Frontline Therapy in Chronic Lymphocytic Leukemia
$79.95
60%off
$48.45
Own This Book? Sell It
9781842140604
ISBN:1842140604
Publisher: C R C Press LLC Summary: This is the only authoritative, detailed clinical reference on Campath-1H, which stands alone among monoclonal antibodies because its reciprocal antigen CD52 is expressed in diverse cell types, and its further potential for clinical practice in hemato-oncology in the treatment of B-cell chronic lymphocytic leukemia. It records the development and actions of Campath-1H, presents the unique clinical, immunological and [read more]- 30-Day No-Hassle Returns
- Fast, Same-Day Customer Service
- The Best Prices on Textbook Rentals
- Find student loan options quickly and easily
- Compare loans to find the best fit for you
- Apply for the loan that meets your needs
9781842140604
ISBN:
1842140604
Publisher: C R C Press LLC
This is the only authoritative, detailed clinical reference on Campath-1H, which stands alone among monoclonal antibodies because its reciprocal antigen CD52 is expressed in diverse cell types, and its further potential for clinical practice in hemato-oncology in the treatment of B-cell chronic lymphocytic leukemia. It records the development and actions of Campath-1H, presents the unique clinical, immunological and molecular features of B-cell chronic lymphocytic leukemia, and explores the potential of Campath-1H as frontline therapy for patients with B-CLL. The book contains five main chapters on B-cell chronic lymphocytic leukemia, the road to remission (from single agent intervention to combination therapy and onward), monoclonal antibodies in cancer (the development of Campath-1H), Campath-1H in B-CLL (remissions of refractory disease), and the role of Campath-1H prior to bone marrow transplant in refractory B-CLL plus a concluding chapter on future perspectives. Includes bibliographic references andindex.
- Track your recent orders.
- See our shipping rates & policies.
- Return an item (here's our Return Policy).
